Menu
← Oncology Approval Tracker
FDA DECISION ·
Akeega
niraparib + abiraterone acetate · Janssen Biotech
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
With prednisone for adults with metastatic castration-sensitive prostate cancer and a deleterious or suspected deleterious BRCA2 mutation on an FDA-approved test.
LAMPGEN ANALYSIS
Why it matters
The label moves PARP inhibition into BRCA2-mutated disease before the castration-resistant stage.
What research teams should watch
Obtain the BRCA2 result early in metastatic care and plan hematologic, hepatic, blood pressure, and steroid adherence checks.
PRIMARY RECORDS